Targeting the vital non-structural proteins (NSP12, NSP7, NSP8 and NSP3) from SARS-CoV-2 and inhibition of RNA polymerase by natural bioactive compound naringenin as a promising drug candidate against COVID-19
- 26 April 2023
- journal article
- research article
- Published by Elsevier in Journal of Molecular Structure
- Vol. 1287, 135642
Abstract
No abstract availableKeywords
This publication has 62 references indexed in Scilit:
- Biochemical characterization of a recombinant SARS coronavirus nsp12 RNA-dependent RNA polymerase capable of copying viral RNA templatesArchives of Virology, 2012
- The SARS-coronavirus nsp7+nsp8 complex is a unique multimeric RNA polymerase capable of both de novo initiation and primer extensionNucleic Acids Research, 2011
- AutoDock Vina: Improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreadingJournal of Computational Chemistry, 2009
- Coronaviruses post-SARS: update on replication and pathogenesisNature Reviews Microbiology, 2009
- AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibilityJournal of Computational Chemistry, 2009
- The spike protein of SARS-CoV — a target for vaccine and therapeutic developmentNature Reviews Microbiology, 2009
- Hepatitis C virus production by human hepatocytes dependent on assembly and secretion of very low-density lipoproteinsProceedings of the National Academy of Sciences, 2007
- Animal Origins of the Severe Acute Respiratory Syndrome Coronavirus: Insight from ACE2-S-Protein InteractionsJournal of Virology, 2006
- GROMACS: Fast, flexible, and freeJournal of Computational Chemistry, 2005
- UCSF Chimera—A visualization system for exploratory research and analysisJournal of Computational Chemistry, 2004